RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
RPL22L1 是一种新型候选致癌基因,可通过激活胶质母细胞瘤中的 STAT3 来促进替莫唑胺耐药性
期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-023-06156-6
Yunping Chen #, Yu Mu #, Qing Guan #, Chenlong Li, Yangong Zhang, Yinzhi Xu, Chong Zhou, Ying Guo, Yanan Ma, Meiqi Zhao, Guohua Ji, Peng Liu, Donglin Sun, Haiming Sun, Nan Wu, Yan Jin